Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Rallybio (RLYB) Shares Outstanding (2023 - 2025)

Rallybio (RLYB) has disclosed Shares Outstanding for 3 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.82% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, up 1.82% year-over-year, with the annual reading at $5.3 million for FY2025, 1.82% up from the prior year.
  • Shares Outstanding hit $5.3 million in Q4 2025 for Rallybio, down from $41.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.9 million in Q3 2025 to a low of $4.7 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $31.2 million across 3 years, with a median of $37.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 0.17% in 2024 and later increased 10.05% in 2025.
  • Year by year, Shares Outstanding stood at $4.7 million in 2023, then grew by 9.73% to $5.2 million in 2024, then rose by 1.82% to $5.3 million in 2025.
  • Business Quant data shows Shares Outstanding for RLYB at $5.3 million in Q4 2025, $41.9 million in Q3 2025, and $41.7 million in Q2 2025.